Vikran Engineering, Anlon Healthcare IPO listing date: Key details to know before market debut

Shares of Vikran Engineering and Anlon Healthcare are all set to make their stock market debuts, following the successful bidding period and share allotments.

Shares of these two companies will be listed on the National Stock Exchange (NSE) and BSE (formerly Bombay Stock Exchange).

Vikran Engineering, Anlon Healthcare IPO listing date

Shares of Vikran Engineering and Anlon Healthcare will start trading on bourses at 10 am on Wednesday.

Vikran Engineering IPO

• Vikran Engineering IPO subscription details: The issue has been booked 23.59 times during the three-day trading window, with bids for 1,38,59,19,508 shares compared to 5,87,39,128 shares on offer. The part for non-institutional investors was subscribed 58.58 times, while the qualified institutional buyers' portion was booked 19.45 times. Retail investors subscribed to their category 10.97 times.
• Objectives: The ₹772 crore public offer consists of a fresh issuance of shares valued at ₹721 crore and an offer for sale, or OFS, of ₹51 crore. The money generated will be used for general corporate purposes and working capital requirements.
• Financials: The company had posted a revenue from operations of 915.84 crore in the financial year 2024-25, up 16.52% compared to 785.94 crore a year back. Net profit rose 3.98% to 77.81 crore vs 74.83 in the previous fiscal year.

Anlon Healthcare IPO

• Anlon Engineering IPO subscription details:The initial share sale received bids for 9,47,62,808 shares, which is 7.13 times higher than the 1,33,00,000 shares on offer. The retail investors' part was booked 47.30 times, while the non-institutional investors' portion was subscribed 10.61 times. The portion reserved for qualified institutional buyers secured a 1.07 times subscription.
• Objectives: The IPO was purely a fresh issuance of shares valued at ₹121.03 crore. The funds generated will be utilised for capital expenditure needs, debt clearance, general corporate purposes and working capital requirements.
• Financials: The company's revenue from operations rose 80.65% to 120.28 crore in FY25 as compared to 66.58 crore a year back. PAT advanced 112.53% to 20.51 crore in the fiscal year 2024-25, vs 9.65 crore in the same period a year ago.